Tuesday 18 March 2025 06:48 GMT

Canary Capital Files For First Sui ETF Amid Growing Institutional Interest


(MENAFN- eTrendy Stock) Canary Capital has filed an S-1 registration with the U.S. Securities and Exchange Commission to launch the first ETF for Sui, marking a significant development for institutional adoption of the Layer 1 blockchain. If approved, the ETF would trade on major stock exchanges offering both institutional and retail investors direct exposure to SUI without the need for direct token custody.

This filing follows Canary's earlier registration of the“Canary Sui ETF” in Delaware on March 6, indicating a move toward federal approval. It also comes after World Liberty financial (WLFI), a decentralized finance project tied to President Donald Trump, announced plans to include SUI in its strategic reserves.

Canary Capital CEO Steven McClurg discussed the rapid expansion of the Sui ecosystem, noting an influx of developers and projects.

Institutional Demand for Crypto ETFs

Crypto ETFs are gaining traction as asset managers push for broader exposure beyond Bitcoin and Ethereum. Since the SEC approved spot BTC and ETH ETFs in 2024, firms have filed for altcoin-based ETFs, including Solana, XRP, Litecoin, and Dogecoin.

Canary Capital's Sui ETF filing is its sixth crypto ETF application, joining those for Litecoin, Hedera, Axelar, XRP, and Solana. Other firms are also moving quickly-Franklin Templeton filed for an XRP ETF, Bitwise submitted an application for an Aptos ETF, and VanEck is pursuing an Avalanche (AVAX) ETF.

Despite these efforts, the SEC has delayed decisions on several ETF applications, citing standard review procedures. However, recent regulatory shifts suggest a more open stance, with the agency dropping lawsuits against major crypto firms and forming a dedicated crypto task force.

MENAFN18032025007158015398ID1109325949


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search